Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
TAAR5 Biologics Sequence Review Report 2026: Trace amine-associated receptor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TAAR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
SSTR4 Biologics Sequence Review Report 2026: Somatostatin receptor type 4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
SSTR5 Biologics Sequence Review Report 2026: Somatostatin receptor type 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
SSTR3 Biologics Sequence Review Report 2026: Somatostatin receptor type 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
SSTR1 Biologics Sequence Review Report 2026: Somatostatin receptor type 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
SCTR Biologics Sequence Review Report 2026: Secretin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SCTR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
RAMP2 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
RAMP3 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
RET Biologics Sequence Review Report 2026: Proto-oncogene tyrosine-protein kinase receptor Ret Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RET protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTH2R Biologics Sequence Review Report 2026: Parathyroid hormone 2 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTH2R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
RAMP1 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTGIR Biologics Sequence Review Report 2026: Prostacyclin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTGIR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
240
241
242
243
244
>>
1905
>